- Supported exchanges /
- SHE /
- 002038.SHE
Beijing SL Pharmaceutical Co Ltd (002038 SHE) stock market data APIs
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide capsules; docetaxel; paclitaxel; recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; liraglutide; insulin aspart 30; insulin aspart 50; insulin aspart; recombinant human follitropin(rh-fsh); ciclosporin; mycophenolate mofetil dispersible; voriconazole; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; rivaroxaban; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin; paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is headquartered in Beijing, the People's Republic of China.
Beijing SL Pharmaceutical Co Ltd Financial Data Overview
| 7.13 | |
| 7.41 | |
| - | |
| 7.43 | |
| 7.11 | |
| 6.16-12.3341 | |
| 7 387 M | |
| 89.875 | |
| 1 027 M | |
| 782 M | |
| -0.0451 | |
| 0.0202 | |
| 0.352 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Beijing SL Pharmaceutical Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 782 M
- EBITDA 245 M
- Earnings Per Share 0.08
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Beijing SL Pharmaceutical Co Ltd Earnings via APIs
- Latest Release 2024-10-26
- EPS/Forecast NaN
Get Beijing SL Pharmaceutical Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
